SCHEMBL2950069

SCHEMBL2950069

Nc1nc(N)c2ncn(C3CCC(N4CCOCC4)CC3)c2n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 4/20 0.49
PI4KA P42356 3/20 0.44
PI4K2B Q8TCG2 3/20 0.44
PI4K2A Q9BTU6 3/20 0.44
PI4KB Q9UBF8 3/20 0.44
ADORA3 P0DMS8 2/20 0.44
ADORA1 P30542 2/20 0.44
ADORA2B P29275 1/20 0.44
AHCY P23526 1/20 0.44
HRH3 Q9Y5N1 2/20 0.43
JAK1 P23458 1/20 0.41
CHKA P35790 4/20 0.40
CDK1 P06493 2/20 0.40
CCNB1 P14635 2/20 0.40
CCNE1 P24864 2/20 0.40
CDK2 P24941 2/20 0.40
CHKB Q9Y259 2/20 0.39
CYP1A2 P05177 1/20 0.39
TSHR P16473 1/20 0.39
MAP4K4 O95819 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2949862 0.88 ADORA2A (0.51) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL15941621 0.86 ADORA2A (0.63) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL17352601 0.81 ADORA2A (0.65) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL2954550 0.79 ADORA2A (0.66) ADORA2API4KAPI4K2BPI4K2API4KB
Hydrochloric Acid SCHEMBL5626685 0.79 AHCY (0.48) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL2953211 0.78 ADORA2A (0.48) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL2952924 0.77 ADORA2A (0.51) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL17822227 0.76 FLT3 (0.56) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL6108014 0.75 HRH3 (0.40) HRH3JAK1MAP4K4
Hydrochloric Acid SCHEMBL7846299 0.74 AHCY (0.54) ADORA2API4KAPI4K2BPI4K2API4KB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010111406-A2 COMPOUNDS AND THERAPEUTIC USES THEREOF MYRIAD PHARMACEUTICALS, INC. (US) 2010-09-30 WO claimed